Oaktree Acquisition Corp. II (OACC) vs Translational Development Acquisition Corp. (TDAC)

A side-by-side comparison of Oaktree Acquisition Corp. II and Translational Development Acquisition Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — OACC vs TDAC

growth of $100 · dividends reinvested · last 2y
OACC +7.5% (+3.7%/yr)TDAC +8.2% (+4.0%/yr)TDAC compounded faster over this window
100102104106108Start $1002026$107$108
OACC TDAC

OACC vs TDAC: by the numbers

  • •TDAC is the larger company ($267M vs $265M market cap).
  • •OACC trades at the lower trailing earnings multiple (38.08 vs 42.08 P/E), one valuation lens rather than an overall verdict.

Metrics side by side

Valuation

MetricOACCTDAC
P/E ratio38.0842.08
P/B ratio1.341.78

Profitability

MetricOACCTDAC
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE3.41%3.70%
ROIC-0.59%-0.84%

Frequently asked

Which has the lower trailing P/E, OACC or TDAC?
OACC has the lower trailing P/E: OACC trades at 38.08 and TDAC at 42.08. P/E is one valuation measure and does not by itself establish which business is cheaper.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.